Patents by Inventor Michael K. White

Michael K. White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BISPECIFIC BINDING MOLECULES
    Publication number: 20250304691
    Abstract: The present disclosure provides novel bispecific molecules that binds to human Survivin and human CD3, and methods of making and using the same.
    Type: Application
    Filed: March 19, 2025
    Publication date: October 2, 2025
    Inventors: Adam Chervin, Feng Dong, Edward B. Reilly, Jennifer Stone, Michael K. White
  • BISPECIFIC BINDING MOLECULES
    Publication number: 20220306740
    Abstract: The present disclosure provides novel bispecific molecules that binds to human Survivin and human CD3, and methods of making and using the same.
    Type: Application
    Filed: November 1, 2021
    Publication date: September 29, 2022
    Inventors: Adam S. Chervin, Feng Dong, Edward B. Reilly, Jennifer D. Stone, Michael K. White
  • BISPECIFIC BINDING MOLECULES
    Publication number: 20210253700
    Abstract: The present disclosure provides novel bispecific molecules that binds to human Survivin and human CD3, and methods of making and using the same.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 19, 2021
    Inventors: Adam S. Chervin, Feng Dong, Edward B. Reilly, Jennifer D. Stone, MIchael K. White
  • Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
    Patent number: 8734793
    Abstract: Recombinant antibodies, including chimeric antibodies, specific for hepatitis C (HCV) antigenic proteins are provided. The recombinant antibodies specifically bind to diagnostically relevant regions of HCV proteins and are thus suitable for use, for example, as diagnostic reagents for the detection of HCV, and/or as standardization reagents or positive control reagents in assays for the detection of HCV. The recombinant antibodies can also be used in the treatment or prevention of a HCV infection.
    Type: Grant
    Filed: November 22, 2010
    Date of Patent: May 27, 2014
    Assignee: Abbott Laboratories Inc.
    Inventors: Bailin Tu, Joan D. Tyner, James W. Scheffel, Michael K. White, Jeffrey M. Werneke, Robert N. Ziemann, David J. Hawksworth, Mary S. Pinkus, Robin A. Gutierrez
  • RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF OBTAINING AND USING SAME
    Publication number: 20110263436
    Abstract: Recombinant antibodies, including chimeric antibodies, specific for hepatitis C (HCV) antigenic proteins are provided. The recombinant antibodies specifically bind to diagnostically relevant regions of HCV proteins and are thus suitable for use, for example, as diagnostic reagents for the detection of HCV, and/or as standardization reagents or positive control reagents in assays for the detection of HCV. The recombinant antibodies can also be used in the treatment or prevention of a HCV infection.
    Type: Application
    Filed: November 22, 2010
    Publication date: October 27, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Bailin Tu, Joan D. Tyner, James W. Scheffel, Michael K. White, Jeffrey M. Werneke, Robert N. Ziemann, David J. Hawksworth, Mary S. Pinkus, Robin A. Gutierrez
  • Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
    Patent number: 7858752
    Abstract: Recombinant antibodies, including chimeric antibodies, specific for hepatitis C (HCV) antigenic proteins are provided. The recombinant antibodies specifically bind to diagnostically relevant regions of HCV proteins and are thus suitable for use, for example, as diagnostic reagents for the detection of HCV, and/or as standardization reagents or positive control reagents in assays for the detection of HCV. The recombinant antibodies can also be used in the treatment or prevention of a HCV infection.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: December 28, 2010
    Assignee: Abbott Laboratories
    Inventors: Bailin Tu, Joan D. Tyner, James W. Scheffel, Michael K. White, Jeffrey M. Werneke, Robert N. Ziemann, David J. Hawksworth, Mary S. Pinkus, Robin A. Gutierrez
  • Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
    Publication number: 20080131912
    Abstract: Recombinant antibodies, including chimeric antibodies, specific for hepatitis C (HCV) antigenic proteins are provided. The recombinant antibodies specifically bind to diagnostically relevant regions of HCV proteins and are thus suitable for use, for example, as diagnostic reagents for the detection of HCV, and/or as standardization reagents or positive control reagents in assays for the detection of HCV. The recombinant antibodies can also be used in the treatment or prevention of a HCV infection.
    Type: Application
    Filed: December 5, 2006
    Publication date: June 5, 2008
    Inventors: Bailin Tu, Joan D. Tyner, James W. Scheffel, Michael K. White, Jeffrey M. Werneke, Robert N. Ziemann, David J. Hawksworth, Mary S. Pinkus, Robin A. Gutierrez